The global subcutaneous drug delivery devices market size was estimated at USD 23 billion in 2021 and is anticipated to expand at a CAGR of 11% between 2023 to 2032.
Usually there are three ways to deliver medication in patient’s body – oral drug delivery, intravenous drug delivery and subcutaneous drug delivery. Subcutaneous drug delivery refers the type of medication being given to the patient in which drug is injected into the tissue layer between the muscles and skin. These kinds of injections are shallower than those injected in the muscles directly. Subcutaneous type of drug delivery is preferred when a continuous dose of medication (such as insulin) is prescribed.
Cost efficiency is also one of the major reasons causing this kind of drug delivery to propel over the years. This kind of medical administration allows the patient to self-medicate themselves in home and allows significant amount of reduction in medical facility administration cost.
Moreover rise in number of chronic diseases among the people due to their lifestyle habits is one of the major factors driving the growth of the global subcutaneous drug delivery devices market. Covid-19 has further made it more compelling for the patients to carry out in-house medication as it would be harmful for these patients to go to healthcare facilities to get their routine medications.
North America has the major revenue share in the global subcutaneous drug delivery devices market throughout the forecast period of 2020 to 2030. This is majorly attributed to increasing cases of chronic diseases among the population in this region. For instance, according to the National Diabetes Statistics report by Centers for Disease Control & Prevention (CDC) states that in 2018, almost 10.5% of the U.S. population or 35.2 million of people had diabetes and the trend of increasing diabetic patients has been observed for the past years. Asia Pacific is expected to be the most lucrative market for the global subcutaneous drug delivery devices market players. APAC is growing with the highest CAGR during the forecast period of 2020-2030.
Low labor and manufacturing cost in this region will help the global players to increase their manufacturing capabilities and profit margins. Moreover, developing healthcare infrastructure in this region is providing gold mine of opportunities for the companies operating in the market.
Subcutaneous Drug Delivery Devices Market Value Share Analysis, by Geography (2022)
The report titled “subcutaneous drug delivery Market- Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global subcutaneous drug delivery devices Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global subcutaneous drug delivery devices market is segmented on the basis of product type, distribution channel, usability and geography. Based on product type the market is segmented on the basis of auto-injectors, pre-filled syringes, pen injectors, wearable injectors, and needle free injection. Wearable and needle free injectors are expected to grow at highest CAGR during the forecast period of 2020 to 2030. Based on distribution channel the market is segmented into hospital pharmacies, retail pharmacies and online consultation providers. Hospital pharmacies have major revenue share in the global subcutaneous drug delivery devices market. Rising number of solo clinics/laboratories is further driving the market. Online consultation is the fastest growing segment during the forecast period. This is mainly due to the unique discounts over pricing offered by these consultation providers. On the basis of usability the market is divided into disposable devices and re-usable devices. Re-usable devices segment is having higher CAGR throughout the forecast period as these devices seems to be cost efficient solution over a longer period of time.
Based on geography, the global subcutaneous drug delivery devices Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, South Korea, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on subcutaneous drug delivery devices. Further, market share of prominent companies in the global subcutaneous drug delivery devices Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focusing on the subcutaneous drug delivery devices companies. The global subcutaneous drug delivery devices Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the subcutaneous drug delivery devices segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global subcutaneous drug delivery devices market.
Major players active in the global subcutaneous drug delivery devices market include Gerresheimer AG, Ypsomed AG, Novo Nordisk, Becton, Dickinson and Company, PharmaJet, Inolife Sciences , Medtronic Plc, Elcam Medical Group, Insulet Corporation, West Pharmaceutical Services, Inc. and Unilife Corporation.
Product innovation and strategic partnerships are some of the key focus areas of the major players operating in the market. Integrating their devices with connectivity solutions will help the manufacturers to maintain the competitive edge over the other players in the market.
Segmentation:
By Product type:
By Usability:
By Distribution Channel:
By Geography :
The global Subcutaneous Drug Delivery Devices market segmented on the basis of Product type, Usability, Distribution Channel and Geography.
The major active players are Gerresheimer AG, Ypsomed AG, Novo Nordisk, Becton, Dickinson and Company, PharmaJet, Inolife Sciences , Medtronic Plc, Elcam Medical Group, Insulet Corporation, West Pharmaceutical Services, Inc. and Unilife Corporation.
The sample report for the Subcutaneous Drug Delivery Devices Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved